Form 4 for RGNX REGENXBIO Inc.
Accepted 2021-12-06 00:00:00 ET · period of report 2021-12-02 · accession 0001562180-21-007473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | 2021-12-02 | RGNX | Mills Kenneth T. | Pres, CEO, Dir | G - Gift | $0.00 | -3,300 | 277.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-02 | G | D | 3,300 | $0.00 | 277,684 | D | — | — | (F1) This transaction involved an irrevocable gift of securities by the Reporting Person to a charitable donor advised fund. |